Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Patterson Companies, Inc. (PDCO)

    Price:

    31.33 USD

    ( - -0.28 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    PDCO
    Name
    Patterson Companies, Inc.
    Industry
    Medical - Distribution
    Sector
    Healthcare
    Price
    31.330
    Market Cap
    2.772B
    Enterprise value
    3.044B
    Currency
    USD
    Ceo
    Donald J. Zurbay
    Full Time Employees
    7600
    Ipo Date
    1992-10-28
    City
    Saint Paul
    Address
    1031 Mendota Heights Road

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Akso Health Group

    VALUE SCORE:

    0

    Symbol
    HX
    Market Cap
    53.371M
    Industry
    Medical - Distribution
    Sector
    Healthcare

    2nd position

    Ridgetech Inc.

    VALUE SCORE:

    9

    Symbol
    RDGT
    Market Cap
    7.699M
    Industry
    Medical - Distribution
    Sector
    Healthcare

    The best

    Great Elm Group, Inc.

    VALUE SCORE:

    12

    Symbol
    GEG
    Market Cap
    68.029M
    Industry
    Medical - Distribution
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    19.936
    P/S
    0.426
    P/B
    2.796
    Debt/Equity
    0.580
    EV/FCF
    -3.701
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.493
    Earnings yield
    0.050
    Debt/assets
    0.203
    FUNDAMENTALS
    Net debt/ebidta
    1.357
    Interest coverage
    4.103
    Research And Developement To Revenue
    0.002
    Intangile to total assets
    0.117
    Capex to operating cash flow
    -0.078
    Capex to revenue
    0.010
    Capex to depreciation
    1.003
    Return on tangible assets
    0.055
    Debt to market cap
    0.207
    Piotroski Score
    4.000
    FUNDAMENTALS
    PEG
    -1.489
    P/CF
    -3.439
    P/FCF
    -3.195
    RoA %
    4.899
    RoIC %
    8.993
    Gross Profit Margin %
    20.468
    Quick Ratio
    0.726
    Current Ratio
    1.408
    Net Profit Margin %
    2.131
    Net-Net
    -10.311
    FUNDAMENTALS PER SHARE
    FCF per share
    -9.823
    Revenue per share
    73.734
    Net income per share
    1.572
    Operating cash flow per share
    -9.111
    Free cash flow per share
    -9.823
    Cash per share
    1.529
    Book value per share
    11.210
    Tangible book value per share
    7.471
    Shareholders equity per share
    11.206
    Interest debt per share
    7.049
    TECHNICAL
    52 weeks high
    31.790
    52 weeks low
    19.450
    Current trading session High
    31.330
    Current trading session Low
    31.330
    DIVIDEND
    Dividend yield
    0.830%
    Payout ratio
    66.6%
    Years of div. Increase
    1.000
    Years of div.
    15.000
    Q-shift
    2.000
    Dividend per share
    0.260
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Distribution
    Dividend yield
    0%
    Payout Ratio
    32.810204999999996%
    P/E
    17.696

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Distribution
    Dividend yield
    0.012883311%
    Payout Ratio
    31.64638%
    P/E
    24.156
    logo

    Country
    FR
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.382
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Distribution
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    20.289
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Distribution
    Dividend yield
    0.0039034071%
    Payout Ratio
    11.156763999999999%
    P/E
    29.833
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Distribution
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.302
    DESCRIPTION

    Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.

    NEWS
    https://images.financialmodelingprep.com/news/patterson-companies-completes-acquisition-by-patient-square-capital-20250422.jpg
    Patterson Companies Completes Acquisition by Patient Square Capital

    businesswire.com

    2025-04-22 09:00:00

    ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (“Patterson” or the “Company”), a leading supplier of products and services to the dental and animal health end markets, successfully completed its acquisition by Patient Square Capital (“Patient Square”), a dedicated health care investment firm, on April 17, 2025. As a result of this transaction, Patterson's common stock is no longer traded on the NASDAQ Global Select Market. In conjunction with the closing of the acquisition, Patterson is.

    https://images.financialmodelingprep.com/news/sterling-infrastructure-set-to-join-sp-smallcap-600-20250414.jpg
    Sterling Infrastructure Set to Join S&P SmallCap 600

    prnewswire.com

    2025-04-14 18:43:00

    NEW YORK , April 14, 2025 /PRNewswire/ -- Sterling Infrastructure Inc. (NASD: STRL) will replace Patterson Companies Inc. (NASD: PDCO) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 17. Patient Square Capital is acquiring Patterson Companies in a deal expected to be completed soon, pending final closing conditions.

    https://images.financialmodelingprep.com/news/patterson-companies-inc-shareholders-approve-acquisition-by-patient-square-20250401.jpg
    Patterson Companies, Inc. Shareholders Approve Acquisition by Patient Square Capital

    businesswire.com

    2025-04-01 13:00:00

    ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (NASDAQ: PDCO), a value-added specialty distributor serving the U.S. and Canadian dental supply markets and the U.S., Canadian and U.K. animal health supply markets, today announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital, a dedicated health care investment firm. Don Zurbay, Patterson's President and Chief Executive Officer, said, “I would like to express my gratitude t.

    https://images.financialmodelingprep.com/news/patterson-cos-pdco-up-03-since-last-earnings-report-20250328.jpg
    Patterson Cos. (PDCO) Up 0.3% Since Last Earnings Report: Can It Continue?

    zacks.com

    2025-03-28 12:35:42

    Patterson Cos. (PDCO) reported earnings 30 days ago.

    https://images.financialmodelingprep.com/news/pdco-q3-earnings-sales-miss-estimates-margins-contract-20250227.jpg
    PDCO Q3 Earnings & Sales Miss Estimates, Margins Contract

    zacks.com

    2025-02-27 09:45:37

    Patterson Companies' overall top-line figure for the third quarter of fiscal 2025 reflects weak segmental performance.

    https://images.financialmodelingprep.com/news/patterson-cos-pdco-q3-earnings-and-revenues-lag-estimates-20250226.jpg
    Patterson Cos. (PDCO) Q3 Earnings and Revenues Lag Estimates

    zacks.com

    2025-02-26 19:35:29

    Patterson Cos. (PDCO) came out with quarterly earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.62 per share.

    https://images.financialmodelingprep.com/news/patterson-companies-reports-fiscal-2025-third-quarter-operating-results-20250226.jpg
    Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results

    businesswire.com

    2025-02-26 16:30:00

    ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025. “As we continue to progress toward closing our transaction with Patient Square Capital, our team remains focused on executing our strategy,” said Don Zurbay, President and CEO of Patterson Companies. “While our third quarter results were impacted by challenging market conditions, we remain confident in the long-term strength of Pat.

    https://images.financialmodelingprep.com/news/pdco-stock-alert-halper-sadeh-llc-is-investigating-whether-20250225.jpg
    PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders

    businesswire.com

    2025-02-25 00:29:00

    NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQ: PDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders. Halper Sadeh encourages Patterson shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth.

    https://images.financialmodelingprep.com/news/patterson-companies-announces-expiration-of-goshop-period-20250121.jpg
    Patterson Companies Announces Expiration of “Go-Shop” Period

    businesswire.com

    2025-01-21 17:00:00

    ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day “go-shop” period under the terms of the previously announced definitive merger agreement, pursuant to which Patient Square Capital, L.P. (“Patient Square”), a dedicated health care investment firm, will acquire Patterson for $31.35 per share, in an all-cash transaction valued at approximately $4.1 billion, including the refinanc.

    https://images.financialmodelingprep.com/news/shareholder-investigation-halper-sadeh-llc-investigates-usap-and-pdco-20250106.jpg
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders

    globenewswire.com

    2025-01-06 14:27:00

    NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

    https://images.financialmodelingprep.com/news/pdco-stock-gains-on-the-news-of-acquisition-deal-20241216.jpg
    PDCO Stock Gains on the News of Acquisition Deal With Patient Square

    zacks.com

    2024-12-16 08:55:14

    Patterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion.

    https://images.financialmodelingprep.com/news/what-does-dental-player-pattersons-41-billion-deal-mean-for-20241212.jpg
    What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?

    benzinga.com

    2024-12-12 14:32:59

    On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc.  PDCO, a dental and animal health product distributor, for approximately $4.1 billion.

    https://images.financialmodelingprep.com/news/patterson-companies-surges-as-the-market-prices-in-more-20241212.jpg
    Patterson Companies Surges As The Market Prices In More Upside (Rating Downgrade)

    seekingalpha.com

    2024-12-12 09:00:00

    Patterson Companies' shares surged 35.9% after announcing an all-cash buyout by Patient Square Capital, valuing the company at $4.1 billion. Despite the buyout, some investors feel the deal leaves money on the table, but the stock's appreciation is a net positive. The go-shop period allows management to seek better offers, suggesting potential for a higher bid, making it wise to hold shares.

    https://images.financialmodelingprep.com/news/hareholder-alert-the-ma-class-action-firm-investigates-the-20241211.jpg
    $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Patterson Companies, Inc. - PDCO

    prnewswire.com

    2024-12-11 17:12:00

    NEW YORK , Dec. 11, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Patterson Companies, Inc. (NASDAQ: PDCO ), relating to the proposed merger with Patient Square Capital.

    https://images.financialmodelingprep.com/news/dental-product-supplier-patterson-companies-goes-private-in-41-20241211.jpg
    Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion Deal

    benzinga.com

    2024-12-11 10:18:16

    On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc.  PDCO, a dental and animal health product distributor, for approximately $4.1 billion.

    https://images.financialmodelingprep.com/news/pdco-stock-alert-halper-sadeh-llc-is-investigating-whether-20241211.jpg
    PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders

    businesswire.com

    2024-12-11 08:41:00

    NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQ: PDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders. Halper Sadeh encourages Patterson shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth.